Abstract
The use of opioids in the setting of abdominal pain has nearly doubled in the last decade, making it a commonplace yet controversial practice. Although initially used predominantly for cancer pain and acute conditions, opioid use for chronic noncancerous pain has steadily increased along with the rates of abuse, misuse, and diversion. The variety of agents available have equally increased in recent years, giving the prescriber much to consider when weighing the drug’s properties with patient-related factors and special issues specific to opioids in the gastrointestinal tract. In light of the variables ultimately leading to the patient’s response, the opioid agent is often changed to a different type of formulation in order to maintain efficacy and minimize side effects. Overall, opioids must be prescribed on an individual basis with frequent monitoring for benefits as well as side effects and evidence of abuse.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
US Department of Health and Human Services, NCHS. Data from the National Hospital Ambulatory Medical Care Survey: 1999–2008. ER department visits for chest pain and abdominal pain: United States. http://www.cdc.gov/nchs/data/databriefs/db43.htm. Accessed 6 Sept 2013.
Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, Kim HP, Dibonaventura MD, Carroll CF, Allen JK, Cook SF, Sandler RS, Kappelman MD, Shaheen NJ. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(5):1179–87.
International Association of Pain. Global year against visceral pain October 2012–October 2013. Epidemiology of abdominal pain. http://www.iasp-pain.org/AM/Template.cfm?Section=Fact_Sheets5%26Template=/CM/ContentDisplay.cfm%26ContentID=16193. Accessed 25 Sept 2013.
Jones AD, Ramakrishnan K. Analgesics in the initial management of acute abdominal pain. Internet J Emerg Med. 2005;2(2). Doi: 10.5580/22ac.
Drossman DA. Severe and refractory chronic abdominal pain: treatment strategies. Clin Gastroenterol Hepatol. 2008;6(9):978–82.
Smith HS, et al. Current therapy in pain. Philadelphia: Saunders Elsevier; 2009.
Manterola C, Astudillo P, et al. Analgesia in patients with acute abdominal pain. Cochrane Database Syst Rev. 2011;19(1), CD005660.
Ranji SR, Goldman LE, et al. Do opiates affect the clinical evaluation of patients with acute abdominal pain? JAMA. 2006;296(14):1764–74.
Australian Government National Health and Research Council. National Institute of Clinical Studies Emergency Care Community of Practice. Evidence in Practice Series 2008. Pain medication for acute abdominal pain, a summary of best available evidence and information on clinical practice. http://www.nhmrc.gov.au/_files_nhmrc/file/nics/material_resources/pain_medication_
aute_abdominal_pain.pdf. Accessed 24 Sept 2013.
Matthew D, Hsien-Yen C, Yuping Y, Viswanathan S, Shah N, Stafford R, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000–2010. Med Care. 2013;51(10):870. doi:10.1097/MLR.0b013e3182a95d86.
Gerson LB. Gastroenterologists and the US epidemic. Gastroenterology. 2012;142(5):1250–3.
Dorn SD, Meek PD, Shah NS. Increasing frequency of opioid prescriptions for chronic abdominal pain in the US outpatient clinics. Clin Gastroenterol Hepatol. 2011;9(12):1078–85.
Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010;59(23):705–9.
Berland D, Rodgers P. Rational use of opioids for management of chronic nonterminal pain. Am Fam Physician. 2012;86(3):252–8.
Chou FR, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.
Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of a aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10(2):131–46.
Ramsin B, Trescot AM, Datta SM, Benyamin MD, et al. Opioid complications and side effects. Pain Physician. 2008;11(2 Suppl):S105–20.
Benzon HT, Raja SN, Molloy RE, Liu SS, Fishman SM. Essentials of pain medicine and regional anesthesia. 2nd ed. Philadelphia: Elsevier; 2005.
Epstein H, Hansen C, Thorson D. A protocol for addressing acute pain and prescribing opioids. Minn Med. 2014;97(4):47–51.
Koneru A, Satyanarayana S, Rizwan S. Endogenous opioids: their physiological role and receptors. Global J Pharmacol. 2009;3(3):149–53.
Argoff CE, Silvershein DI. Comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc. 2009;84(7):602–12.
Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182(5A Supplement):11S–8.
Panchal SJ, Muller-Schwefe PM, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology, and burden. Int J Clin Pract. 2007;61(7):1181–7.
Pasternak GW. Opioids and their receptors, are we there yet? Neuropharmacology. 2014;76 Pt B:198–203.
Helm JF, et al. Effects of morphine on the human sphincter of Oddi. Gut. 1988;29(10):1402–7.
Hubbard GP, Wolfe KR. Meperidine misuse in a patient with sphincter of Oddi dysfunction. Ann pharmacother. 2003;37(4):534–7.
Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001;96(4):1266–72.
Wu SD, et al. Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry. Hepatobiliary Pancreat Dis Int. 2003;2(1):121–5.
Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012;10(6):209–19.
Osborne R, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after afferent routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther. 1990;47:12–9.
Fine PG, Portenoy RK. Strategies for opioid rotation: decision support in chronic pain management. MedScape Education. 2010. http://cme.medscape.com/viewarticle/717832. Accessed 30 Mar 2010.
Fine PG, Portenoy RK. For the ad hoc expert panel on evidence review and guidelines for opioid rotation. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 2009;38:418–25.
Fine PG, Portenoy RK. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 2009;38(3):418–25.
Fine PG, Portenoy RK. A clinical guide to opioid analgesia. New York: Vendome Group, LLC; 2007.
Thomsen AB, Becker N, Eriksen J. Opioid rotation in chronic non-malignant pain patients: a retrospective study. Acta Anaesthesiol Scand. 1999;43(9):918–23.
Pasternak GW. Molecular biology of opioid analgesia. J Pain Symptom Manage. 2005;29(5 suppl):S2–9.
Shooke JE, Pelton JT, Hurby VJ, et al. Peptide opioid antagonist separates peripheral and central antitransit effects. J Pharmacol Exp Ther. 1987;243:492–500.
Manara L, Bianchetti A. The central and peripheral influences of opioids on the gastrointestinal propulsion. Annu Rev Pharmacol Toxicol. 1985;25:249–73.
Margolin S. Decreased gastrointestinal propulsive activity after intracranial morphine. Fed Proc. 1954;13:383–4.
Tamayo AC, Diaz-Zuluaga PA. Management of opioid-induced bowel dysfunction in cancer patients. Support Care Cancer. 2004;12:613–8.
Mancini I, Bruera E. Constipation in advanced cancer patients. Support Care Cancer. 1998;6:356–64.
Wilder-Smith C, Betiga A. The analgesic tramadol has minimal effect on motor gastrointestinal function. Br J Clin Pharmacol. 1997;43:71–5.
Daenick P, Bruera E. Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. J Pain Symptom Manage. 1999;18:303–9.
Radbruch L, Sabatowski R, Loick G, et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med. 2000;14:111–9.
Benzon H, Rathmell J, et al. Raj’s practical pain management. 4th ed. Philadelphia: Mosby Elsevier; 2008.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gutierrez, G.J., Rodante, J., Desai, M.J. (2015). Opioids in Abdominal Pain. In: Kapural, L. (eds) Chronic Abdominal Pain. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1992-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1992-5_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1991-8
Online ISBN: 978-1-4939-1992-5
eBook Packages: MedicineMedicine (R0)